Therapy Areas: Autoimmune
17 September 2018 - - US-based biopharmaceutical company Pfizer Inc. (NYSE: PFE) has released results from its Phase 2a study of PF-06651600, an oral Janus kinase 3 inhibitor, and PF-06700841, a tyros...
17 September 2018 - Hansa Medical AB (Stockholm: HMED), a biopharmaceutical company focused on immunomodulatory enzymes for organ transplantation and acute autoimmune conditions, announced on Monday t...
17 September 2018 - Pfizer Inc (NYSE:PFE) a US-based pharmaceutical company announced on Saturday results from its Phase 2a study of PF-06651600, an oral Janus kinase (JAK) 3 inhibitor, and PF-0670084...
14 September 2018 - - US-based drug and vaccine developer CEL-SCI Corp. (NYSE American: CVM)  has received USD 5,435,367 through the exercise of warrants to purchase shares of the company�...
13 September 2018 - - The US Food and Drug Administration has granted Orphan Drug Designation to SYNT001, US-based biotechnology company Syntimmune, Inc's lead investigational candidate, for the ...
12 September 2018 - - Jersey-based oncology company Novocure (NASDAQ: NVCR) and China-based biopharmaceutical company Zai Lab (NASDAQ: ZLAB) have inked an exclusive license agreement for Tumor Treatin...